The insurance provider has teamed with the city of Wuhan to form a healthcare fund sized at approximately $3bn, with LPs including WeDoctor and Jointown Pharmaceutical.

Varian Medical Systems led University of Michigan's robotic-assisted ultrasound device spinout's series C round, which also included Johnson & Johnson Innovation - JJDC.

Nationwide Children’s-founded advanced pathology platform Deep Lens has now raised $17.5m in all as it looks to grow its business in the clinical trial recruitment segment.

Varian Medical Systems led the robotic-assisted ultrasound device developer's series C round, which also included Johnson & Johnson Innovation - JJDC.

Existing backer Kakao Ventures reinvested in the AI-based drug discovery technology developer as part of an $11.5m round led by Mirae Asset Capital.

Intel Capital and Texas Medical Center Venture Fund were among the participants in an $11.9m round for patient monitoring system developer Medical Informatics.

Boehringer Ingelheim Venture Fund has participated in a $23.8m round for the antibody developer that was co-led by V-Bio Ventures and Advent France Biotechnology.

SMBC, Shinsei Bank, Mitsubishi UFJ and Kyoto Chuo Shinkin all backed cancer therapy developer Chordia Therapeutics’ latest round, which follows a Takeda-backed series A.

Oncology therapeutics developer Fusion Pharmaceticals closed a $105 round, featuring several corporate investors. The deal forms part of the growing broad oncology space, which has seen much attention from corporate venturers in recent years.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.